Proteomics

Dataset Information

0

STARS overexpression in the mdx mouse tibialis anterior muscle increases maximal isometric force production and regulates members of the keratin, NRF2 and OXPHOS pathways


ABSTRACT: Duchenne muscular dystrophy (DMD) is characterized by impaired cytoskeleton organization, cytosolic calcium handling oxidative stress and mitochondrial dysfunction. This results in progressive and fatal muscle damage, wasting and weakness. The Striated Muscle activator of Rho signalling (STARS) is an actin binding protein that activates the myocardin-related transcription factor-A (MRTFA)/serum response factor (SRF) transcriptional pathway; a pathway that regulates cytoskeletal structure, muscle function, growth and repair. Here we investigated the regulation of several members of the STARS signalling pathway in muscle from patients with DMD and the dystrophin-deficient mdx and dko (utrophin‐ and dystrophin‐null) mice. A reduction in protein levels of STARS, SRF and RHOA, and an increase in MRTFA were observed in quadriceps muscle of patients with DMD. STARS, SRF and MRTFA mRNA levels were also decreased in DMD muscle, while Stars mRNA levels were decreased in mdx tibialis anterior (TA) muscle and Srf and Mrtfa mRNAs were decreased in dko TA muscle. Overexpressing the human STARS (hSTARS) protein in mdx TA muscle increased maximal isometric specific force by 13%. This was not associated with changes in muscle mass, fibre cross-sectional area (CSA), fibre type, centralized nuclei or collagen deposition. Proteomics screening identified 31 upregulated and 22 downregulated proteins or individual peptides that were significantly regulated by hSTARS overexpression. Pathway enrichment analysis indicated that hSTARS overexpression regulated the keratin, NRF2 and oxidative phosphorylation (OXPHOS) pathways. These pathways are impaired in dystrophic muscle and regulate cytoskeleton organization, oxidative stress and mitochondrial energy production; processes that are vital for muscle function. We conclude that increasing the STARS protein in dystrophic muscle improves muscle force production, potentially via its regulation of multiple pathways that positively influence cytoskeletal structure, oxidative stress and energy production.

INSTRUMENT(S): TripleTOF 6600

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Striated Muscle Cell, Striated Muscle Tissue

DISEASE(S): Duchenne Muscular Dystrophy

SUBMITTER: Albert Lee  

LAB HEAD: Albert Lee

PROVIDER: PXD024631 | Pride | 2021-08-12

REPOSITORIES: Pride

altmetric image

Publications

Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.

Sadler Kate J KJ   Gatta Paul A Della PAD   Naim Timur T   Wallace Marita A MA   Lee Albert A   Zaw Thiri T   Lindsay Angus A   Chung Roger S RS   Bello Luca L   Pegoraro Elena E   Lamon Séverine S   Lynch Gordon S GS   Russell Aaron P AP  

Experimental physiology 20210527 7


<h4>New findings</h4>What is the central question of this study? Striated muscle activator of rho signalling (STARS) is an actin-binding protein that regulates transcriptional pathways controlling muscle function, growth and myogenesis, processes that are impaired in dystrophic muscle: what is the regulation of the STARS pathway in Duchenne muscular dystrophy (DMD)? What is the main finding and its importance? Members of the STARS signalling pathway are reduced in the quadriceps of patients with  ...[more]

Similar Datasets

2018-10-22 | PXD009680 | Pride
2022-09-14 | E-MTAB-10322 | biostudies-arrayexpress
2019-09-26 | E-MTAB-7698 | biostudies-arrayexpress
2022-11-22 | GSE218370 | GEO
2008-06-15 | E-GEOD-7187 | biostudies-arrayexpress
2019-10-02 | E-MTAB-7287 | biostudies-arrayexpress
2015-09-24 | E-GEOD-64419 | biostudies-arrayexpress
2015-09-24 | E-GEOD-64418 | biostudies-arrayexpress
2007-11-06 | E-GEOD-466 | biostudies-arrayexpress
2022-09-27 | GSE213925 | GEO